Sponsor

BlueRock Therapeutics

Clinical research sponsor

Published trials4
Recruiting shown1
Roles1
SourceClinicalTrials.gov

Clinical trials

4 shown
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseaseNCT06944522 · lead sponsor · 2025-06-17
RECRUITING
Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01NCT05897957 · lead sponsor · 2023-05-16
ENROLLING_BY_INVITATION
Noninterventional Study Evaluating Parkinson's Disease Diary UseNCT05363046 · lead sponsor · 2022-07-29
ACTIVE_NOT_RECRUITING
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's DiseaseNCT04802733 · lead sponsor · 2021-05-03
COMPLETED

Sponsor roles

lead sponsor4

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.